AI discovered skincare treatment reduces skin age metric in trial

Rubedo Life Sciences reported trial findings where a topical cream decreased the epigenetic age marker in skin samples by an average of two years. The formulation was identified using an AI platform designed to locate damaged senescent cells, though larger placebo controlled studies are still required.